J, B., A, D., M, B., T, L., TLF, S., T, M., . . . JA, B. (2026). Tolerability of lopinavir versus dolutegravir in children and adolescents with HIV. AIDS (London, England), 40(5), 600. https://doi.org/10.1097/QAD.0000000000004432
Chicago Style (17th ed.) CitationJ, Blankenberger, et al. "Tolerability of Lopinavir Versus Dolutegravir in Children and Adolescents with HIV." AIDS (London, England) 40, no. 5 (2026): 600. https://doi.org/10.1097/QAD.0000000000004432.
MLA (9th ed.) CitationJ, Blankenberger, et al. "Tolerability of Lopinavir Versus Dolutegravir in Children and Adolescents with HIV." AIDS (London, England), vol. 40, no. 5, 2026, p. 600, https://doi.org/10.1097/QAD.0000000000004432.
Warning: These citations may not always be 100% accurate.